Chapter

When the Rules Change in Midstream

in Science for Sale

Published by University of Chicago Press

Published in print October 2007 | ISBN: 9780226306254
Published online March 2013 | e-ISBN: 9780226306261 | DOI: http://dx.doi.org/10.7208/chicago/9780226306261.003.0011
When the Rules Change in Midstream

Show Summary Details

Preview

This chapter discusses the challenges faced by Saint Louis University (SLU) professor William S.M. Mold in the commercialization of his cancer research. It explains that Mold is the president and CEO of a biotechnology company he founded called VirRx and SLU was uneasy about the propriety of the complex financial arrangements for Wold's research. The SLU's Conflict of Interest Committee deliberated on the issue and decided to move VirRx laboratory to an off-campus location in order to have clear distinction between university business and private business.

Keywords: William S.M. Mold; SLU; cancer research; VirRx; financial arrangements; conflict of interest; university business; private business

Chapter.  5750 words. 

Subjects: Ethical Issues and Debates

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.